Interleukin-4 and immunoglobulin E levels in newborns at risk of atopic diseases
Abstract
Background The clinical syndrome of atopy is associated v.ith the production of immunoglobulin E (lgE) in response to antigenic stimulation as part of a type I hypersensitivity reaction. Since early prevention is regarded as an important cornerstone in the management of atopic diseases, the identification of reliable markers such as IgE and interleukin 4 (IL-4) in detecting individuals at risk are of major interest.
Objective To determine whether cord blood IgE and IL-4 levels can be used as an predictor of atopy in newborns with a family history of atopic diseases.
Methods We conducted a cross-sectional study on healthy-term newborns in the neonatal ward at R.D. Kandou Hospital from June to August 2010. A total of 50 healthy newborns in atopic and non-atopic groups were examined for cord blood IgE and IIA levels.
Result The mean cord blood ILA levels in the atopic and non-atopic groups were 0.1 μg/mL (SD 0.08) and 0.1 μg/mL (SD 0.16) (P=0.359), respectively. The mean cord blood IgE levels in the atopic and non-atopic groups were 2.2 IU/mL (SD 1.98) and 0.5 IU/mL (SD 0.29) (P<0.00l), respectively. A point-biserial correlation coefficient analysis showed no significant correlation between ILA levels and family history of atopic disease (rpb=0.098), and a weak correlation between IgE levels and family history of atopic disease (rpb=0.54).
Conclusions Cord blood IgE and IL-4 levels should not be used to distinguish newborns with a family history of atopic diseases from those without.
References
2. Shah S, Bapat MM. Parental history of allergy, maternal serum IgE and cord serum IgE. Indian j Med Sci. 2006;60.13•8.
3. Herbert G, HeinrichJ, Roder S.R educed IFNô€£o and enhanced ILA producing CD4 cord blood t cell are associated Mth a higher risk for atopic dermatitis during the first 2 years of life. Pediatr Allergy Immunol. 2010;21;5•13.
4. Hutapea AT, Setiabudiawan B, Soepriadi M, Rustama DS. Association between cord blood IgE levels in newborns and family history of atopic disease. Pediatr Indones. 2006;46: 199-203.
5. Croner S, Kjellman NAM, Eriksson B, Roth A. IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Child. 1982;57:364-8.
6. Edenharter G, Bergmann RL, Bergmann KE, F orster Vw, Zepp F, Wahn U. Cord blood-IgE as risk factor and predictor for atopic diseases. Clin Exp Allergy. 1998;28:671-8.
7. Eiriksson TH, Sigurgeirsson B, Ardal B, Sigfusson A, Valdimarsson H. Cord blood IgE levels are influenced by gestational age but do not predict allergic manifestations in infants. Pediatr Allergy Imunol. 1994;5:5-10.
8. Steinke JW, Borish L. Th2 cytokines and asthma Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment Mth interleukinA receptor antagonists. Respir Res. 2001;2:66-70.
9. Moser R, Feehr J, Bruijn PL. ILA controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol. 1992; 149. 1432•8.
10. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir j.1995;8;483-91.
11. Holt PG, Yabuhara A, Presscot S, Venaille T, Macaubas C, Holt BJ, et al. Allergen recognition in the origin of asthma. Ciba F ound Symp. 1997;206.35-49.
12. Harsono A.P encegahan primer penyakit alergi.P resented on 35th Pediatric Continuing Education. Surabaya: Department of Child Heath, Medical School, Airlangga University, 2005; p.79-85.
13. Bones MP, Einarsson R, Bjorksten B. Serum levels of interleukinA, soluble CD23 and IFN gamma in relation to the development of allergic disease during the first 18 months of life. Clin Exp Allergy. 1995;25:543-8.
14. Ohshima Y, Katamura K, Miura M., MikawaH, Mayum i M. Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders. Eur J Pediatr. 1995;154:723-8.
15. Paulsen LK, Bindslev JC, Diamant M, Hansen MB, Jepsen KF, Reimert CM. Biomolecular regulation of the IgE immune response III. Cytokine profiles in atopic dermatitis, inhalant allergy and non-allergic donors. Cytokine. 1996;8:651-7.
16. Wen HJ, Lin YC, Lee YL, Guo YL.Association between cord blood IgE and genetic polymorphisms of interleukin-4, the subunit of the high-affinity receptor for IgE, lymphotoxin-α and tumor necrosis factor-α. Pediatr Allergy Immunol. 2006;17;489-94.
17. Velazquez PSV, Angeles MB. Concentraciones de IgE en sangre de cordon umbilical y su asociacion con factores de riesgo atopico. Educ Invest Clin. 2000; 1: 172-6.
18. Alawar B, El Kalla S, BjorkstCn B. Cord blood IgE levels in the United Arab Emirates. Pediatr Allergy Immunol. 1994;5:59-61.
19. Kobayashi Y, Kondo N, Shinoda S, Agata H, Fukutomi 0, Orii T. Predictive values of cord blood IgE and cord blood lymphocyte responses to food antigens in allergic disorders during infancy. J Allergy Clin Immunol. 1994;94:907-16.
20. Romagnani S, Del Prete G, Maggi E, Parronchi P, Ricci M. New insights into the mechanisms which regulate IgE synthesis in man. Haematologica. 1992;74:317- 23.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2016-10-17
Published 2011-02-28
